Petros Pharmaceuticals Inc (PTPI)
0.655
+0.02
(+2.36%)
USD |
NASDAQ |
Apr 26, 11:37
Petros Pharmaceuticals Cash from Operations (TTM): -7.626M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -7.626M |
September 30, 2023 | -6.937M |
June 30, 2023 | -4.642M |
March 31, 2023 | -8.27M |
December 31, 2022 | -12.80M |
September 30, 2022 | -19.53M |
June 30, 2022 | -18.99M |
Date | Value |
---|---|
March 31, 2022 | -16.69M |
December 31, 2021 | -11.86M |
September 30, 2021 | -8.081M |
June 30, 2021 | -9.536M |
March 31, 2021 | -13.38M |
December 31, 2020 | -15.31M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-19.53M
Minimum
Sep 2022
-4.642M
Maximum
Jun 2023
-11.82M
Average
-11.86M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
Avalo Therapeutics Inc | -30.68M |
Spectral AI Inc | -- |
Imunon Inc | -19.02M |
Assembly Biosciences Inc | 22.74M |
iBio Inc | -18.89M |